FDA Inspection 1243840 — Southern Blood Services Inc
The FDA completed an inspection of Southern Blood Services Inc on Jun 20, 2024 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 20, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)